Each brand has a well-defined identity, with a specific values which are reflected in the product offering, features and design, as well as in appropriate communication mechanics.
We remain convinced that our balanced business model, combining profitable growth and a resolutely responsible approach, creates value for all and plays a full part in our contribution to better living in households around the world.
02:30 pm (CET)
General Meeting
05:40 pm (CET)
2024 Half-year sales and results
9-month 2024 sales and financial data
Independent Director
BPIFRANCE INVESTISSEMENT specializes in fund management. It is represented on the Board of Directors by Guillaume Mortelier.
Date of first appointment: 2022 End date of term of office: AG 2026
Guillaume Mortelier is a graduate of the Ecole Polytechnique and the Ecole Nationale des Ponts et Chaussées. Ecole Nationale des Ponts et Chaussées. Guillaume Mortelier began his career in 2003 with Bain & Company in Company in Paris and San Francisco, where he led business development in Europe and North America. Between 2007 and 2012, he made equity investments in French ETIs within the Astorg Partners fund Astorg Partners fund, then in foreign companies (mainly in the Mediterranean and China) with Proparco. In September 2012, Guillaume Mortelier joined CDC Entreprises, part of Bpifrance of Bpifrance, where he was appointed Director of Development, then Director of Strategy and Development in 2014. In December 2017, he became a member of the Mid & Large Cap Management Committee, in charge of the creation and management of the International Build-up Fund. Guillaume Mortelier was appointed Executive Director in charge of Support on August 1, 2018.
Other offices and positions held outside Groupe SEB at 31/12/2023 > Director - Treasurer of IPEMED > Permanent representative of Bpifrance Investissement on the Board of Directors of Euroapi Positions and offices which have expired over the past 5 years: > Bpifrance Managing Director - Mid & Large Cap